Skip to main content

Advertisement

Table 5 End points at Month 19

From: Impact of patient education on chronic heart failure in primary care (ETIC): a cluster randomised trial

  Intervention (n = 69) Control (n = 82) P-value
Primary outcomes
 SF-36 mental health score, mean (SD) 58 (22.1) 58.7 (23.9) 0.57
 SF-36 physical health score, mean (SD) 52.8 (23.8) 51.6 (25.5) 0.58
 MLHFQ score, mean (SD) 33.4 (22.1) 27.2 (23.3) 0.74
Secondary outcomes
 NYHA stage, n (%)a
  I 14 (22.6) 21 (29.2)  
  II 35 (56.5) 34 (47.2) 0.73
  III 12 (19.3) 15 (20.8)  
  IV 1 (1.6) 2 (2.8)  
 BMI kg/m2, n (%)b
   < 25 13 (22) 29 (40.3)  
  25–30 25 (42.4) 33 (45.8) 0.007
   ≥ 30 21 (35.6) 10 (13.9)  
 Patient adherencec, n (%)
  Good adherence 23 (37.1) 32 (42.1)  
  Minor nonadherence 35 (56.5) 42 (55.3) 0.55
  Nonadherence 4 (6.4) 2 (2.6)  
Mortality, n (%) 10/115 (8.7) 15/126 (11.9) 0.41
Total CHF decompensation/visits (%) 65/470 (13.8) 93/545 (17.1) 0.16
Hospitalisation for CHF decompensation/visits (%) 18/65 (27.7) 22/93 (23.7) 0.57
Hospitalisation not for CHF decompensation/visits (%) 50/470 (10.6) 59/545 (10.8) 0.92
Hospitalisation/visits (%) 62/470 (13.2) 74/545 (13.6) 0.86
Hospitalisation/patients (%) 41/115 (35.7) 54/126 (42.9) 0.26
Total number of days of hospitalisation 1037 867  
HF hospitalisation/patients (%) 13/115 (11.3) 17/126 (13.5) 0.61
Death or hospitalisation/patients (%) 45/115 (39.1) 60/126 (47.6) 0.18
Death or HF hospitalisation/patients (%) 20/115 (17.3) 28/126 (22.2) 0.35
dTotal visits related to GP/patients (%) 90/115 (78 %) 106/126(84 %) 0.24
dNumber of GP visits/patient, mean (SD) 8.1 (5.3) 6.4 (4.5) 0.02
Total visits related to cardiologist/patients (%) 85/115 (74 %) 84/126 (67 %) 0.22
Number of cardiologist visits/patient, mean (SD) 3.1 (2.2) 3.1 (2) 0.92
  1. a n = 17 missing data for New York Heart Association stage
  2. b n = 20 missing data for body mass index
  3. c n = 13 missing data for adherence
  4. dAdditional general practitioner visits (in addition to those dedicated to the study)
  5. Significant P-value are in bold